Highlander Capital Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HEC
FLAM
PCM
Highlander Capital Management's ATRC Position: Q2 2018 in Review
Highlander Capital Management sold out of AtriCure (ATRC) in Q2 2018, closing a stake of 500 shares — an estimated $10K sold.
Highlander Capital Management first reported a position in ATRC in Q2 2013 and held it in 20 quarters. The position peaked at $549K in Q4 2013. 108 funds tracked by Wall St. Rank hold ATRC as of Q2 2018.
- Highlander Capital Management reported no remaining AtriCure position as of Q2 2018 after selling out during the quarter.
- Highlander Capital Management sold 500 AtriCure shares in Q2 2018, an estimated $10K.
- Highlander Capital Management first reported a position in AtriCure in Q2 2013 and held it in 20 quarters.
- Highlander Capital Management's AtriCure position peaked at $549K in Q4 2013.
- 108 funds tracked by Wall St. Rank held AtriCure as of Q2 2018.
Based on Highlander Capital Management's 13F filing for Q2 2018, filed 15 Aug 2018.